A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects

Utility of lidocaine as a topical analgesic and improvements in patch delivery systems

(2020) Jeff Gudin et al.   POSTGRADUATE MEDICINE

Herpes zoster infection

(2019) Phuc Le et al.   BMJ-British Medical Journal

Post-herpetic Neuralgia: a Review

(2016) Graham R. Hadley et al.   Current Pain and Headache Reports

Topical Therapies in the Management of Chronic Pain

(2016) Steven P. Stanos et al.   POSTGRADUATE MEDICINE

Lidocaine Transdermal Patch: Pharmacokinetic Modeling and In Vitro–In Vivo Correlation (IVIVC)

(2015) Phani Krishna Kondamudi et al.   AAPS PHARMSCITECH

Postherpetic Neuralgia

(2014) Robert W. Johnson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider

(2014) Jamie Massengill et al.   Journal of Pain Research

Herpes Zoster

(2013) Jeffrey I. Cohen   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia

(2012) Rainer Sabatowski et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study

(2009) Guy Hans et al.   CURRENT MEDICAL RESEARCH AND OPINION